{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:08:53Z","timestamp":1785262133614,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,14]]},"DOI":"10.7759\/cureus.84101","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:48:41Z","timestamp":1747234121000},"source":"Crossref","is-referenced-by-count":2,"title":["Managing Chemotherapy-Associated Cardiotoxicity: A Case of 5-Fluorouracil and Mitomycin-Induced Chest Pain"],"prefix":"10.7759","author":[{"given":"Sonal","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirali","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor E","family":"Collignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Hadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.07.026","article-title":"Capecitabine-induced chest pain relieved by diltiazem","volume":"110","author":"Ambrosy AP","year":"2012","unstructured":"Ambrosy AP, Kunz PL, Fisher GA, Witteles RM. Capecitabine-induced chest pain relieved by diltiazem. Am J Cardiol. 2012, 110:1623-6. 10.1016\/j.amjcard.2012.07.026","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2366","article-title":"Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Simoff MJ","year":"2013","unstructured":"Simoff MJ, Lally B, Slade MG, et al.. Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013, 143:e455S-97S. 10.1378\/chest.12-2366","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2377","article-title":"Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Detterbeck FC","year":"2013","unstructured":"Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013, 143:7S-37S. 10.1378\/chest.12-2377","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12558","article-title":"A retrospective review and treatment paradigm of interventional therapies for patients suffering from intractable thoracic chest wall pain in the oncologic population","volume":"16","author":"Gulati A","year":"2015","unstructured":"Gulati A, Shah R, Puttanniah V, Hung JC, Malhotra V. A retrospective review and treatment paradigm of interventional therapies for patients suffering from intractable thoracic chest wall pain in the oncologic population. Pain Med. 2015, 16:802-10. 10.1111\/pme.12558","journal-title":"Pain Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Swarm RA","year":"2019","unstructured":"Swarm RA, Paice JA, Anghelescu DL, et al.. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019, 17:977-1007. 10.6004\/jnccn.2019.0038","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association","volume":"128","author":"Lipshultz SE","year":"2013","unstructured":"Lipshultz SE, Adams MJ, Colan SD, et al.. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013, 128:1927-95. 10.1161\/CIR.0b013e3182a88099","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk A","year":"2013","unstructured":"Polk A, Vaage-Nilsen M, Vistisen K, Nielsen DL. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev. 2013, 39:974-84. 10.1016\/j.ctrv.2013.03.005","journal-title":"Cancer Treat Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194426","article-title":"Cardiotoxicity of fluoropyrimidines: epidemiology, mechanisms, diagnosis, and management","volume":"10","author":"Jurczyk M","year":"2021","unstructured":"Jurczyk M, Kr\u00f3l M, Midro A, Kurnik-\u0141ucka M, Poniatowski A, Gil K. Cardiotoxicity of fluoropyrimidines: epidemiology, mechanisms, diagnosis, and management. J Clin Med. 2021, 10:4426. 10.3390\/jcm10194426","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13536","article-title":"Myocardial ischemia induced by 5-fluorouracil: a prospective electrocardiographic and cardiac biomarker study","volume":"26","author":"Dyhl-Polk A","year":"2021","unstructured":"Dyhl-Polk A, Schou M, Vistisen KK, et al.. Myocardial ischemia induced by 5-fluorouracil: a prospective electrocardiographic and cardiac biomarker study. Oncologist. 2021, 26:e403-13. 10.1002\/onco.13536","journal-title":"Oncologist"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051244","article-title":"The role of vasospasm and microcirculatory dysfunction in fluoropyrimidine-induced ischemic heart disease","volume":"11","author":"Fabin N","year":"2022","unstructured":"Fabin N, Bergami M, Cenko E, Bugiardini R, Manfrini O. The role of vasospasm and microcirculatory dysfunction in fluoropyrimidine-induced ischemic heart disease. J Clin Med. 2022, 11:1244. 10.3390\/jcm11051244","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357826-managing-chemotherapy-associated-cardiotoxicity-a-case-of-5-fluorouracil-and-mitomycin-induced-chest-pain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:48:41Z","timestamp":1747234121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357826-managing-chemotherapy-associated-cardiotoxicity-a-case-of-5-fluorouracil-and-mitomycin-induced-chest-pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.84101","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,14]]}}}